DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INSULATARD NPH HUMAN

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

All Clinical Trials for Insulatard Nph Human

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00346996	Insulin Analogues and Severe Hypoglycaemia	Completed	Novo Nordisk A/S	Phase 4	2007-05-01	Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00346996	Insulin Analogues and Severe Hypoglycaemia	Completed	Lise Tarnow	Phase 4	2007-05-01	Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00566124	Basal Insulins - Pharmacodynamics	Completed	Novo Nordisk A/S	Phase 4	2005-01-01	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124	Basal Insulins - Pharmacodynamics	Completed	The Danish Diabetes Association	Phase 4	2005-01-01	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124	Basal Insulins - Pharmacodynamics	Completed	The Institute of Experimental Clinical Research, University of Aarhus	Phase 4	2005-01-01	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124	Basal Insulins - Pharmacodynamics	Completed	University of Aarhus	Phase 4	2005-01-01	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00657930	Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)	Completed	Novo Nordisk A/S	N/A	2008-03-01	This study is conducted in Europe. The aim of this observational study is to gain practical experience with once-daily Levemir administration in type 2 diabetes patients who were previously treated with Insulatard®, Humulin® N (NPH insulins) as basal insulin as part of their ICT under normal clinical practice conditions in Hungary.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary